ADHD Testing: How ADHD Is Diagnosed and Why There Is No Single Test

ADHD testing is an evaluation rather than a test. A clinician documents the DSM-5-TR symptom criteria, gathers reports from people who see the person in at least two different settings, establishes that symptoms were present before age 12, confirms that they measurably interfere with functioning, and rules out the other conditions that produce the same behavior. The Centers for Disease Control and Prevention states the point without hedging: there is no single test to diagnose ADHD.

This page covers the criteria an evaluation has to document, who may make the diagnosis, what gets ruled out, how the school route differs from the clinical route, what computerized attention tests can settle, and what the process costs. Cognitive testing often appears in the same file without carrying the diagnosis; our article on IQ testing and ADHD covers what a Wechsler profile contributes.

The reason is structural. Every criterion the diagnosis rests on describes a pattern across months and across situations, and no procedure administered once in one room can observe that pattern.

• The symptoms have to persist: DSM-5-TR requires that they have lasted at least six months at a level inconsistent with developmental level. A snapshot cannot establish duration, so the evidence has to come from people who have watched the person over time.

• The symptoms have to appear in more than one place: The manual requires that several symptoms be present "in two or more settings (e.g., at home, school, or work; with friends or relatives; in other activities)." Home and school are the usual pair for a child, which means the evaluation needs at least two informants who do not live in the same house.

• There has to be real impairment: DSM-5-TR asks for "clear evidence that the symptoms interfere with, or reduce the quality of, social, academic, or occupational functioning." Symptom counts alone do not satisfy this, and much of the disagreement between clinicians is really disagreement about where the impairment threshold sits.

The American Academy of Pediatrics, in its 2019 clinical practice guideline, tells clinicians to reach the diagnosis "with information obtained primarily from reports from parents or guardians, teachers, other school personnel, and mental health clinicians who are involved in the child or adolescent's care." The same guideline is blunt about the alternative: "The use of neuropsychological testing has not been found to improve diagnostic accuracy in most cases, although it may have benefit in clarifying the child or adolescent's learning strengths and weaknesses."

The multi-informant requirement is where the measurement difficulty lives. Narad and colleagues analyzed parent and teacher ADHD ratings for 6,659 children aged 4 to 17 and found parent-teacher correlations that were weak for inattention and only moderate to strong for hyperactivity and impulsivity, with parents reporting more severe symptoms, even after confirming that both groups were rating the same underlying construct. Each reporter supplies unique and valid information, and neither is the answer key. Polanczyk and colleagues arrive at the same place from a different direction: across 135 prevalence studies spanning three decades, the variation in how common ADHD appears was explained mostly by methodology, specifically the diagnostic criteria used, the impairment criterion applied, and the source of information consulted.

DSM-5-TR is the controlling text. It defines ADHD as "a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development," and lists nine inattention symptoms and nine hyperactivity-impulsivity symptoms.

• The symptom count is age-graded: Six or more symptoms from either list are required, and the manual's note adds that "for older adolescents and adults (age 17 and older), at least five symptoms are required." The threshold applies within a list. Four inattention symptoms plus four hyperactivity symptoms do not add up to a diagnosis.

• Onset is before age 12: The wording is that "several inattentive or hyperactive-impulsive symptoms were present prior to age 12 years." The criterion asks for several symptoms rather than the full diagnostic count, which is what makes retrospective adult histories workable. DSM-IV set this boundary at age 7.

• Two settings, again with "several": Criterion C also asks for several symptoms in two or more settings rather than a full count in each. This is the most frequently misread sentence in the set, and it matters, because parents and teachers routinely endorse different symptoms.

• Other explanations are excluded: Symptoms must not occur exclusively during a psychotic disorder and must not be better explained by another mental disorder, with the manual naming mood, anxiety, dissociative and personality disorders and substance intoxication or withdrawal. Autism spectrum disorder is not an exclusion, which was a deliberate change in DSM-5.

The diagnosis is recorded as one of three presentations, predominantly inattentive (F90.0), predominantly hyperactive/impulsive (F90.1) or combined (F90.2), with a current severity of mild, moderate or severe. Rating scales exist to collect these judgments systematically rather than to replace them. Our article on the Conners test explains how a behavior rating scale's T scores work and why a T score is a different animal from an IQ score.

No licensed specialty owns this diagnosis. In practice it is made by pediatricians and other primary care clinicians, child and adolescent psychiatrists, clinical and school psychologists working within their licensure, psychiatric nurse practitioners, and in many places licensed clinical social workers and licensed professional counselors. The AAP guideline is written on the assumption that primary care will carry most of the volume, reasoning that the number of affected children "is far greater than can be managed by the mental health system."

What each of those professionals may do, and under what supervision, is a matter of state law rather than national rule. Scope of practice, the right to bill particular assessment codes, and prescriptive authority are set jurisdiction by jurisdiction, so the same credential does not buy the same authority in two states. A family that needs a diagnosis a prescriber will act on should ask about that before booking.

Cost varies as widely as authority does. A diagnostic visit with a clinician working from DSM-5-TR criteria and rating scales is billed as an office visit and is inexpensive relative to a battery. A psychological or neuropsychological assessment adds hours of face-to-face testing plus scoring and interpretation, billed under separate procedure codes, and payers commonly require prior authorization and apply their own medical-necessity criteria. Two families in the same city can pay amounts differing by an order of magnitude for a diagnosis reached from identical criteria.

Inattention, restlessness and impulsivity are among the least specific symptoms in child mental health. The AAP guideline makes screening for other conditions a separate recommendation, directing clinicians to look for emotional and behavioral conditions such as anxiety, depression, oppositional defiant disorder, conduct disorder and substance use, developmental conditions such as learning and language disorders and autism, and physical conditions including tics and sleep apnea.

Sleep-disordered breathing deserves its own mention because it is treatable and easy to miss. Sedky, Bennett and Carvalho pooled 18 studies covering 1,113 children in clinical groups and 1,405 controls and found a medium-sized association with ADHD symptoms (Hedges' g = 0.57). Uncorrected hearing and vision problems, thyroid disease, iron deficiency, absence seizures, medication side effects and the aftermath of trauma belong on the same list. So does the possibility that the schoolwork is too hard, since a child who cannot decode the text in front of them will look inattentive during reading.

Comorbidity rather than substitution is the usual finding. In the 2022 National Survey of Children's Health, 77.9% of children with current ADHD had at least one co-occurring disorder, and 58.1% were rated moderate or severe. Ruling other things out is not the same as ruling them irrelevant.

A clinic asks whether DSM-5-TR criteria are met. A district asks whether the child is eligible for services under federal education law, a legal determination rather than a medical one, and a district does not issue a DSM diagnosis.

Under the IDEA regulations, ADHD reaches eligibility through the "other health impairment" category, which 34 CFR 300.8(c)(9) defines as "having limited strength, vitality, or alertness, including a heightened alertness to environmental stimuli, that results in limited alertness with respect to the educational environment" due to chronic or acute health problems, a list naming "attention deficit disorder or attention deficit hyperactivity disorder" explicitly, and which "adversely affects a child's educational performance." That last clause does real work. The AAP guideline states the consequence for families: ADHD qualifies as a disability under a Section 504 plan, and it does not qualify for an individualized education program unless its severity impairs the child's ability to learn. Eligibility decisions, the guideline warns, "can vary considerably between school districts."

The same regulations carry the clearest legal statement of this article's theme. A public agency conducting an evaluation must "not use any single measure or assessment as the sole criterion for determining whether a child is a child with a disability," and must "use a variety of assessment tools and strategies." Our article on the psychoeducational evaluation covers what a school battery contains and how eligibility gets decided.

A continuous performance test asks the examinee to respond to some stimuli and withhold responses to others for ten to twenty minutes, scoring omissions, commissions, reaction time and reaction-time variability. Several commercial versions are marketed for ADHD assessment. They measure something real, and they cannot deliver a diagnosis.

Arrondo and colleagues pooled 19 studies of commercially available CPTs against clinical diagnosis in children and adolescents. The areas under the curve were, in their words, "barely acceptable (between 0.7 and 0.8) for the most part." Pooled sensitivity and specificity were 0.75 and 0.71 for the total or ADHD composite, 0.63 and 0.74 for omissions, and 0.59 and 0.66 for commissions. Their conclusion: "CPTs as a stand-alone tool have only a modest to moderate ability to differentiate ADHD from non-ADHD samples. Hence, they should be used only within a more comprehensive diagnostic process." Hall and colleagues reached a compatible verdict in an earlier review of 60 articles.

Set those figures against a base rate. At a specificity of 0.71, roughly three in ten people without ADHD are flagged. A measure with those operating characteristics is useful converging evidence and a poor basis for a medication decision on its own. The same reasoning applies to EEG-based and eye-tracking products sold as objective ADHD tests: ask what the sensitivity and specificity are, and against what reference standard.

No. No laboratory test, genetic panel, EEG measure or neuroimaging finding is accurate enough at the individual level to diagnose ADHD, and none appears in the DSM-5-TR criteria. Medical testing during an evaluation is there to rule other conditions out.

A focused primary care evaluation can be finished across two visits plus the time parent and teacher rating scales take to come back. A psychological or neuropsychological assessment usually runs several hours of testing across one or two appointments, with a separate feedback session.

No. A school team determines eligibility for services under federal education law, a different question from a clinical diagnosis, and districts differ in how they apply that standard. A district report and a clinic report can therefore reach different-looking conclusions about the same child.

That is the normal case rather than a failure of the process. Parent and teacher ratings of inattention correlate only weakly even when both raters use the same underlying construct, so a competent evaluator treats the discrepancy as information about where the behavior shows up instead of averaging it away.

The same criteria apply with a lower threshold, five of nine symptoms rather than six from age 17, and the evaluation has to reconstruct childhood onset from school records, parent report or the person's own history. An estimated 15.5 million US adults, or 6.0%, had a current diagnosis in 2023, and about half received it after turning 18.

ADHD testing is a convergence problem. The criteria demand duration, cross-situational consistency and demonstrated impairment, so the evidence has to come from several people who have watched the person in different places over months, and no instrument administered in a clinic supplies that by itself. The best computerized measures reach sensitivity around 0.75 and specificity around 0.71 against clinical diagnosis, respectable for a screening aid and nowhere near sufficient alone. Federal education regulation writes the same principle into law when it forbids using any single measure as the sole criterion for identifying a disability. A good evaluation is identifiable less by which instruments it used than by whether it gathered independent information from more than one setting and said plainly what it ruled out. If you want a carefully normed cognitive score to sit alongside that clinical work rather than in place of it, you can take a full-length online IQ test built by psychometricians and bring the report to the clinician doing the diagnostic work.

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.), pp. 68-70. doi.org

2. American Psychiatric Association. (2013). Attention deficit/hyperactivity disorder (DSM-5 fact sheet). psychiatry.org

3. Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., Holbrook, J. R., Lehmann, C. U., Lessin, H. R., Okechukwu, K., Pierce, K. L., Winner, J. D., & Zurhellen, W. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4), e20192528. doi.org

4. Centers for Disease Control and Prevention. (2026). Diagnosing ADHD. cdc.gov

5. Arrondo, G., Mulraney, M., Iturmendi-Sabater, I., Musullulu, H., Gambra, L., Niculcea, T., Banaschewski, T., Simonoff, E., Döpfner, M., Hinshaw, S. P., Coghill, D., & Cortese, S. (2024). Systematic review and meta-analysis: Clinical utility of continuous performance tests for the identification of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 63(2), 154-171. doi.org

6. Hall, C. L., Valentine, A. Z., Groom, M. J., Walker, G. M., Sayal, K., Daley, D., & Hollis, C. (2016). The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: A systematic review. European Child & Adolescent Psychiatry, 25(7), 677-699. doi.org

7. Narad, M. E., Garner, A. A., Peugh, J. L., Tamm, L., Antonini, T. N., Kingery, K. M., Simon, J. O., & Epstein, J. N. (2015). Parent-teacher agreement on ADHD symptoms across development. Psychological Assessment, 27(1), 239-248. doi.org

8. Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014). ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis. International Journal of Epidemiology, 43(2), 434-442. doi.org

9. Sedky, K., Bennett, D. S., & Carvalho, K. S. (2014). Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: A meta-analysis. Sleep Medicine Reviews, 18(4), 349-356. doi.org

10. Danielson, M. L., Claussen, A. H., Bitsko, R. H., Katz, S. M., Newsome, K., Blumberg, S. J., Kogan, M. D., & Ghandour, R. (2024). ADHD prevalence among U.S. children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. Journal of Clinical Child & Adolescent Psychology, 53(3), 343-360. doi.org

11. Staley, B. S., Robinson, L. R., Claussen, A. H., Katz, S. M., Danielson, M. L., Summers, A. D., Farr, S. L., Blumberg, S. J., & Tulchinsky, T. (2024). Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults, National Center for Health Statistics Rapid Surveys System, October-November 2023. MMWR. Morbidity and Mortality Weekly Report, 73(40), 890-895. doi.org

12. Assistance to States for the Education of Children With Disabilities: Child with a disability, 34 C.F.R. § 300.8 (2026). ecfr.gov

13. Assistance to States for the Education of Children With Disabilities: Evaluation procedures, 34 C.F.R. § 300.304 (2026). ecfr.gov

Hero image: a classroom at Ryther, a children's psychiatric institution in Seattle, by Joe Mabel, licensed CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0). Via Wikimedia Commons.